Superworth

Imunon EPS IMNN

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$3.99
Latest quarter, Q2 FY26
−$0.54
Fiscal year 2025
−$7.91

Imunon's earnings per share was −$3.99 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.54.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$7.91n/a
FY2024−$22.32n/a
FY2023−$32.70n/a
FY2022n/an/a
FY2021−$58.20n/a
FY2020−$157.50n/a
FY2019−$175.50n/a
FY2018−$150.75n/a
FY2017−$1080.00n/a
FY2016−$2670.75n/a
FY2015−$3307.50n/a
FY2014−$4378.50n/a
FY2013−$3244.50n/a
FY2012−$10788.75n/a
FY2011−$16443.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.54n/a−$3.99
Q1 FY26−$0.84n/a−$5.60
Q4 FY25−$1.45n/a−$7.91
Q3 FY25−$1.16n/a−$9.58
Q2 FY25−$2.15n/a−$12.18
Q1 FY25−$3.15n/a−$17.67
Q4 FY24−$3.12n/a−$22.32
Q3 FY24−$3.76n/a−$27.00
Q2 FY24−$7.64n/a−$28.79
Q1 FY24−$7.80n/a−$30.30
Q4 FY23−$7.80n/a−$32.70
Q3 FY23−$5.55n/a−$47.70

Against its peers

Companies in Healthcare nearest Imunon's size, closest first, today.

CompanyEPS, 12 monthsGrowth
IMNNImunon−$3.99
NEPHNephros$0.16+33% a year
ATNMActinium Pharmaceuticals$0.36
APTAlpha Pro Tech$0.41+24% a year
SPROSpero Therapeutics$0.11
Peer median$0.26

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Imunon

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.